neisseria
gonorrhoea
one
preval
sexual
transmit
diseas
worldwid
million
new
infect
per
year
lack
intens
research
last
decad
increas
resist
recommend
antibiot
call
better
understand
gonococc
infect
fast
diagnost
therapeut
measur
n
gonorrhoea
therefor
aim
work
identifi
novel
immunogen
protein
first
step
advanc
unresolv
problem
identif
immunogen
protein
phorf
oligopeptid
phage
display
librari
entir
n
gonorrhoea
genom
construct
sever
immunogen
oligopeptid
identifi
use
polyclon
rabbit
antibodi
n
gonorrhoea
correspond
fulllength
protein
identifi
oligopeptid
express
immunogen
charact
verifi
elisa
immunogen
charact
six
protein
identifi
first
time
addit
protein
verifi
immunogen
protein
n
gonorrhoea
neisseria
gonorrhoea
gramneg
pathogen
usual
appear
diplococci
strictli
limit
human
host
belong
genu
neisseria
also
includ
human
pathogen
neisseria
meningitidi
sever
nonpathogen
speci
e
g
neisseria
lactamica
neisseria
cinerea
n
gonorrhoea
often
abbrevi
gonococcu
caus
agent
gonorrhoea
one
common
sexual
transmit
infect
sti
estim
number
million
new
infect
worldwid
colon
urogenit
epitheli
cell
shift
upper
genit
tract
lead
pelvic
inflammatori
diseas
pid
women
rare
case
gonococc
infect
caus
steril
men
infertil
women
implic
pid
furthermor
recent
studi
mention
gonococc
infect
increas
hiv
transmiss
rate
given
around
gonococc
infect
women
lesser
extent
men
asymptomat
treatment
well
diagnosi
hinder
sinc
advent
antibiot
treatment
n
gonorrhoea
challeng
stay
ahead
gonococc
evolut
due
pathogen
exceed
abil
dna
gene
uptak
abl
develop
resist
variou
formerli
use
antibiot
class
e
g
sulfanilamid
penicillin
tetracyclin
recent
fluoroquinolon
potenti
lead
evolut
futur
superbug
late
resist
strain
last
line
defenceth
cephalosporin
ceftriaxonewer
isol
differ
part
world
henc
better
understand
n
gonorrhoea
infect
virul
could
facilit
new
treatment
gonorrhoea
elucid
novel
immunogen
protein
could
provid
first
indic
crucial
protein
involv
gonococc
pathogen
anoth
applic
immunogen
protein
develop
vaccin
due
multipl
evas
mechan
circumv
immun
respons
e
g
antigen
variabl
surfac
structur
well
product
iga
proteas
minim
antibodi
gener
detect
infect
furthermor
immun
respons
primarili
occur
mucos
level
sustain
lead
potenti
high
reinfect
rate
even
strain
reason
develop
vaccin
complex
immedi
sight
nevertheless
examin
determin
novel
immunogen
protein
specif
way
treatment
n
gonorrhoea
could
possibl
found
instanc
inactiv
virul
associ
protein
prevent
infect
specif
disturb
essenti
cell
process
top
immunogen
protein
could
use
develop
diagnost
tool
easytous
system
state
art
gonococc
diagnosi
isol
cultiv
follow
gram
stain
identifi
n
gonorrhoea
simultan
screen
antibiot
resist
drawback
long
incub
time
insensit
asymptomat
infect
possibl
altern
includ
nucleic
acid
amplif
test
naat
mani
advantag
e
g
easi
specimen
collect
insuscept
transport
time
save
still
conduct
laboratori
personnel
distinguish
differ
antibiot
resist
sinc
larg
number
infect
occur
asymptomat
mani
peopl
suffer
sti
feel
asham
see
physician
would
great
benefit
easytous
inexpens
diagnost
tool
urin
test
strip
identifi
n
gonorrhoea
cell
urin
due
antigen
variabl
limit
knowledg
lack
suitabl
protein
henc
challeng
might
overcom
identifi
novel
immunogen
protein
target
develop
detect
method
vaccin
research
furthermor
identifi
protein
might
elucid
mechan
gonococc
infect
commonli
identif
immunogen
protein
perform
immunoblot
follow
mass
spectrometri
time
labour
consum
express
proteom
screen
nitrocellulos
membran
recent
microarray
techniqu
howev
method
certain
disadvantag
approach
express
librari
cdna
limit
detect
differenti
express
protein
e
g
hostpathogen
interact
weakli
express
protein
protein
molecular
weight
kda
express
librari
complet
proteom
entail
complex
product
purif
procedur
furthermor
screen
thousand
clone
accomplish
contrast
phage
display
antigen
may
avoid
limit
phage
display
technolog
invent
georg
p
smith
thirti
year
ago
technolog
mainli
use
antibodi
select
also
appli
identifi
immunogen
protein
genom
cdna
librari
phorf
approach
genom
librari
pathogen
clone
phagemid
packag
hyperphag
orf
select
improv
librari
qualiti
oligopeptid
protein
domain
display
surfac
phage
particl
correspond
genet
inform
phagemid
packag
phage
particl
thu
phenotyp
protein
fragment
coupl
genotyp
correspond
gene
fragment
use
polyclon
antibodi
patient
anim
sera
immunogen
oligopeptid
select
pan
procedur
technolog
allow
discoveri
immunogen
protein
independ
pathogen
cultiv
thu
also
identifi
protein
express
patient
vivo
host
pathogen
context
method
use
success
identifi
list
novel
biomark
salmonella
typhimurium
mycoplasma
hyopneumonia
technolog
also
use
identifi
biomark
tick
compar
compet
technolog
like
protein
cultiv
pathogen
follow
immunoblot
use
sera
mass
spectrometri
phorf
technolog
also
allow
identifi
protein
express
hostpathogen
interact
protein
smaller
kda
method
serex
work
lytic
phage
phage
display
system
also
use
simpl
open
read
frame
enrich
increas
librari
qualiti
studi
success
construct
phage
display
librari
whole
genom
n
gonorrhoea
coverag
fold
compar
calcul
theoret
number
insert
two
three
consecut
round
pan
final
screen
polyclon
rabbit
antibodi
n
gonorrhoea
potenti
immunogen
oligopeptid
identifi
thirteen
correspond
protein
express
fulllength
immunogen
charact
thereof
verifi
six
fulllength
protein
identifi
immunogen
first
time
remain
identifi
oligopeptid
describ
literatur
within
close
relat
pathogen
neisseria
meningitidi
immunogen
charact
protein
valid
n
gonorrhoea
studi
furthermor
protein
model
phage
display
oligopeptid
map
obtain
model
indic
part
protein
higher
immunogen
charact
obtain
immunogen
protein
could
serv
promis
candid
clarif
gonococc
infect
develop
effect
agent
n
gonorrhoea
construct
n
gonorrhoea
genom
phage
display
librari
genom
dna
n
gonorrhoea
fragment
sonic
clone
result
three
librari
x
x
x
independ
clone
averag
insert
size
bp
bp
bp
respect
librari
cover
theoret
requir
number
clone
x
x
x
fold
insert
rate
size
analys
coloni
pcr
fig
sequenc
eight
randomli
pick
clone
librari
use
coloni
pcr
addit
seven
per
librari
pick
sequenc
librari
insert
rate
insert
rang
bp
bp
librari
pool
result
averag
insert
length
bp
use
hyperphag
packag
packag
librari
check
number
insert
coloni
pcr
fig
correct
infram
insert
sequenc
clone
librari
infram
insert
ratio
approxim
infram
insert
rate
increas
hyperphag
packag
averag
insert
size
bp
pan
screen
oligopeptid
phage
polyclon
rabbit
antibodi
n
gonorrhoea
use
pan
round
individu
clone
pick
two
three
pan
round
clone
pick
two
three
round
pan
sinc
binder
low
affin
remov
pan
process
result
best
binder
three
consecut
pan
round
advantag
isol
recombin
antibodi
howev
case
immunogen
protein
would
ideal
identifi
protein
immunogen
charact
regardless
affin
total
oligopeptid
phage
clone
produc
analys
elisa
averag
valu
neg
control
subtract
valu
clone
higher
signal
analys
sequenc
twentyon
differ
gene
identifi
check
similar
blast
tabl
furthermor
phage
particl
present
differ
part
gene
identifi
exemplari
see
fig
thirteen
identifi
protein
describ
literatur
eight
oligopeptid
exhibit
homolog
known
antigen
one
clone
carri
part
two
last
bp
noncod
part
bp
bp
gene
chosen
characteris
immunogen
charact
encod
protein
eight
potenti
immunogen
protein
sever
control
chosen
fulllength
protein
product
tabl
addit
glutam
racemas
obtain
pan
howev
dismiss
screen
due
low
signal
intens
elisa
use
neg
control
total
protein
chosen
recombin
express
escherichia
coli
protein
label
asterisk
tabl
borrelia
burgdorferi
neg
control
identifi
oligopeptid
describ
immunogen
literatur
produc
fulllength
protein
compar
tabl
furthermor
three
protein
known
immunogen
charact
n
meningitidi
localis
predict
noncytoplasm
express
fulllength
howev
protein
known
immunogen
mani
bacteria
protein
investig
high
extent
n
meningitidi
produc
fulllength
protein
fulllength
gene
amplifi
fig
posit
clone
identifi
coloni
pcr
sequenc
transform
protein
except
select
posit
control
isol
outer
membran
vesicl
vaccin
n
lactamica
n
meningitidi
express
purifi
affin
chromatographi
use
polyhistidinetag
protein
fig
appli
posit
control
sinc
also
found
outer
membran
vesicl
vaccin
n
lactamica
n
meningitidi
express
harbour
pelb
leader
sequenc
length
amino
acid
protein
appar
molecular
mass
kda
kda
detect
sdspage
latter
correspond
plu
leader
sequenc
smaller
band
correspond
alon
product
recombin
result
two
differ
variant
aros
predict
signal
sequenc
amino
acid
express
fulllength
antigen
valid
elisa
use
three
commerci
avail
polyclon
antibodi
differ
immunis
fig
detect
high
signal
elisa
protein
elisa
signal
cutoff
howev
cutoff
furthermor
lowest
signal
intens
sampl
elisa
express
protein
borrelia
burgdorferi
appli
neg
control
select
three
consecut
round
pan
show
low
signal
intens
screen
elisa
henc
cutoff
set
fourfold
signal
intens
blank
signal
intens
buffer
control
subtract
verifi
protein
express
put
phage
associ
protein
rather
rna
transcript
gene
realtim
pcr
conduct
rna
integr
number
protein
model
predict
novel
immunogen
protein
use
itass
psiblast
appli
three
iter
search
homologu
pdb
databas
summari
best
hit
protein
found
supplementari
section
number
insert
found
screen
differ
insert
size
present
differ
part
protein
list
protein
locu
tag
mark
asterisk
chosen
fulllength
product
verifi
immunogen
charact
tabl
identifi
oligopeptid
isol
phage
display
map
protein
model
monomer
shape
fig
multimer
protein
correspond
oligopeptid
also
highlight
closest
homologu
gain
insight
access
immunogen
region
predict
locat
cytoplasm
membran
identifi
oligopeptid
locat
ctermin
end
protein
span
three
helic
two
closest
structur
homologu
hetero
tetram
haemophilu
influenza
consist
two
ident
protein
span
membran
two
ident
protein
extend
cytoplasm
oligopeptid
identifi
also
locat
protein
cterminu
includ
one
one
closest
structur
homologu
homo
hexam
lysteria
monocytogen
like
organis
cyclic
assembl
illustr
fig
oligopeptid
identifi
ntermin
part
protein
exhibit
oligopeptid
middl
protein
model
check
reliabl
qmean
qmean
score
follow
low
qmean
score
itass
cscore
model
indic
low
reliabl
impli
protein
structur
function
gonorrhoea
differ
immunis
use
two
protein
appli
neg
control
red
column
protein
b
burgdorferi
express
purifi
ident
condit
glutam
racemas
cutoff
set
fourfold
signal
neg
control
blank
intens
buffer
control
subtract
sampl
appli
posit
control
green
column
investig
protein
immunogen
charact
previous
unknown
colour
light
grey
protein
known
immunogen
charact
n
meningitidi
colour
dark
grey
sever
immunoproteom
studi
conduct
investig
immunogen
protein
n
meningitidi
human
pathogen
close
relat
n
gonorrhoea
furthermor
revers
vaccinolog
appli
identifi
antigen
neisseria
strain
includ
effect
outer
membran
vesicl
vaccin
contrast
immunoproteom
studi
n
gonorrhoea
avail
yet
work
conduct
immunoproteom
approach
identifi
novel
immunogen
protein
n
gonorrhoea
due
low
antibodi
titer
human
human
sera
access
henc
polyclon
rabbit
antibodi
n
gonorrhoea
appli
pan
screen
screen
phorf
phage
display
librari
success
yield
number
previous
unknown
immunogen
protein
identif
novel
immunogen
protein
might
grant
addit
insight
role
pathogen
virul
n
gonorrhoea
furthermor
protein
involv
pathogen
pathway
might
serv
potenti
candid
therapeut
treatment
altogeth
oligopeptid
identifi
phage
display
screen
polyclon
rabbit
antibodi
n
gonorrhoea
fa
furthermor
sever
differ
oligopeptid
cover
divers
part
protein
identifi
indic
numer
part
said
protein
recognis
potenti
epitop
region
thirteen
oligopeptid
produc
fulllength
protein
valid
immunogen
charact
serv
control
six
protein
identifi
immunogen
immunogen
charact
success
valid
elisa
abc
transport
atpbind
protein
involv
transport
zincmanganes
local
predict
cytoplasm
membran
phage
display
oligopeptid
locat
ctermin
end
protein
indic
immunogen
part
protein
closest
homolog
structur
identifi
itass
put
metalchel
type
abc
transport
haemophilu
influenza
occur
hetero
tetram
two
ident
chain
compar
queri
align
sequenc
oligopeptid
identifi
phage
display
map
part
protein
embed
membran
fig
therefor
identifi
oligopeptid
access
antibodi
rais
hand
like
protein
face
inward
cytoplasm
hinder
access
antibodi
outsid
howev
local
orient
predict
make
necessari
investig
interestingli
homolog
amino
acid
level
orf
potenti
pathogen
island
e
coli
describ
underlin
possibl
influenc
pathogen
n
gonorrhoea
furthermor
homologu
n
meningitidi
found
upregul
low
zinc
level
condit
often
occur
infect
human
host
cell
delet
mutant
lack
could
provid
inform
import
protein
viabil
virul
n
gonorrhoea
depend
impact
could
attract
target
novel
therapeut
treatment
n
gonorrhoea
highli
conserv
host
factori
bind
protein
abbrevi
hfq
function
modul
posttranscript
regul
stress
respons
rna
chaperon
known
play
vital
role
virul
differ
bacteria
includ
n
meningitidi
furthermor
shown
delet
homologu
n
meningitidi
lead
differenti
express
determin
itass
transport
h
influenza
embed
cytoplasm
membran
h
multimer
model
closest
homologu
determin
itass
rnabind
hfq
protein
l
monocytogen
orf
result
alter
bacteri
growth
rate
reduc
adher
epitheli
cell
show
high
signal
intens
rang
posit
control
homologu
shown
take
cyclic
hexamer
shape
closest
homolog
structur
identifi
itass
hfq
protein
l
monocytogen
sequenc
coverag
howev
last
amino
acid
sequenc
cover
closest
structur
homologu
identifi
oligopeptid
span
precis
last
amino
acid
ctermin
end
protein
though
henc
larger
part
identifi
oligopeptid
includ
predict
model
homolog
structur
sinc
locat
cytoplasm
oligopeptid
access
cell
membran
disrupt
annot
trna
pseudouridin
synthas
b
respons
synthesi
pseudouridin
util
trna
highli
conserv
neisseria
speci
ident
closest
structur
homologu
identifi
itass
trna
pseudouridin
synthas
trub
e
coli
occur
monom
qmean
score
qualiti
estim
yield
good
model
reliabl
anoth
novel
immunogen
protein
name
dnabind
protein
hu
involv
control
gene
express
dna
transact
bacteria
homologu
n
meningitidi
includ
outer
membran
prepar
outer
membran
vaccin
two
differ
studi
shown
upregul
gonococc
delet
mutant
lack
dam
replac
gene
involv
dna
synthesi
furthermor
homologu
e
coli
induc
treatment
cell
uv
mitomycin
c
henc
involv
dna
repair
certain
stress
situat
could
also
case
cell
adhes
infect
annot
hypothet
protein
put
phage
associ
protein
thu
knowledg
express
function
rather
limit
consequ
realtim
pcr
analysi
perform
valid
presenc
mrna
code
protein
shown
gene
encod
transcrib
mrna
result
express
accord
protein
cultur
laboratori
condit
nevertheless
function
bacteriophag
found
n
gonorrhoea
although
genom
region
relat
lysogen
phage
howev
region
includ
assum
encod
incomplet
phage
genom
henc
might
protein
bacteriophag
origin
novel
yet
unknown
function
n
gonorrhoea
blast
result
show
high
ident
hit
within
n
gonorrhoea
strain
strain
neisseria
speci
carri
gene
futur
studi
monoclon
antibodi
might
reveal
precis
localis
within
cell
well
express
rate
furthermor
function
analysi
protein
might
achiev
gener
delet
mutant
investig
protein
influenc
infect
viabil
gonococc
virul
annot
ribosom
recycl
factor
rrf
involv
recycl
ribosom
upon
translat
show
signal
intens
elisa
fourfold
cutoff
neg
control
compar
signal
studi
e
coli
homologu
show
essenti
bacteri
growth
possibl
target
novel
antibacteri
treatment
contrast
replic
dna
helicas
show
signal
intens
rang
neg
control
fulllength
product
despit
promis
signal
intens
phage
librari
screen
possibl
explan
epitop
inaccess
antibodi
within
fulllength
protein
shorter
oligopeptid
suffer
limit
furthermor
conform
epitop
form
recognis
highli
possibl
secondari
structur
truncat
oligopeptid
fulllength
protein
differ
consequ
essenti
valid
immunogen
charact
fulllength
protein
level
apart
newli
describ
immunogen
protein
method
reveal
sever
protein
describ
literatur
yet
mainli
close
relat
pathogen
n
meningitidi
verifi
immunogen
n
gonorrhoea
fulllength
protein
within
studi
protein
wellknown
immunogen
sever
bacteri
speci
well
n
meningitidi
produc
fulllength
protein
includ
furthermor
two
protein
identifi
describ
immunogen
n
gonorrhoea
outer
membran
protein
piii
chaperonin
kda
subunit
express
fulllength
protein
sinc
one
select
clone
contain
dna
sequenc
proteinsth
last
bp
noncod
part
bp
bp
notabl
noncod
part
includ
three
stop
codon
immunogen
charact
valid
downstream
packag
hyperphag
lead
enrich
open
read
frame
orf
insert
stop
codon
outoffram
arrang
larg
remov
infecti
phage
particl
obtain
code
sequenc
insert
giii
express
fulllength
fusion
protein
sinc
insert
also
contain
start
codon
signal
peptid
accord
signalp
http
wwwcbsdtudkservicessignalp
like
sequenc
code
translat
fusion
protein
phage
coat
protein
piii
follow
periplasm
transloc
e
coli
phage
assembl
henc
deriv
oligopeptid
may
display
select
phage
clone
select
due
display
explain
fulllength
protein
fail
proof
immunogen
elisa
homologu
n
meningitidi
describ
immunogen
identifi
outer
membran
vesicl
sever
protein
express
control
dihydrolipoamid
acetyltransferas
identifi
phage
librari
screen
describ
potenti
candid
vaccin
n
meningitidi
expect
strongli
bound
polyclon
antin
gonorrhoea
rabbit
antibodi
elisa
valid
immunogen
charact
n
gonorrhoea
annot
hypothet
protein
lipoprotein
differ
homologu
homologu
describ
immunogen
protein
n
meningitidi
vaccin
potenti
evalu
promis
vaccin
candid
immunogen
charact
protein
valid
n
gonorrhoea
work
two
differ
protein
chosen
neg
control
one
hand
aminopeptidas
ii
borrelia
burgdorferi
chosen
unrel
n
gonorrhoea
protein
contain
recombin
protein
residu
e
coli
protein
might
present
purif
hand
isol
pan
oligopeptid
show
low
signal
intens
screen
nevertheless
select
third
pan
round
indic
could
possibl
antibodi
bind
event
elisa
fulllength
protein
reveal
higher
signal
intens
could
attribut
low
antibodi
titr
henc
appli
calcul
elisa
cutoff
although
novel
identifi
protein
predict
localis
cytoplasm
except
cytoplasm
membran
futur
investig
necessari
determin
exact
localis
within
cell
two
identifi
dnak
rpllwith
predict
cytoplasm
localis
shown
surfaceexpos
n
meningitidi
n
gonorrhoea
respect
furthermor
sever
periplasm
abc
transport
compar
found
surfaceexpos
n
meningitidi
moreov
homologu
also
detect
outer
membran
fraction
whether
latter
protein
surfaceexpos
remnant
vesicl
product
analys
howev
case
homologu
confirm
surfaceexpos
experi
specif
antibodi
could
give
insight
surfaceexposur
protein
gonococc
infect
threedimension
structur
six
novel
identifi
immunogen
protein
predict
itass
closest
pdb
templat
compar
result
obtain
psiblast
three
iter
templat
obtain
model
usual
found
around
top
ten
psiblast
hit
model
predict
itass
align
best
model
avail
pdb
structur
identifi
pdb
structur
highest
similar
templat
use
predict
protein
quaternari
structur
case
multimer
quaternari
structur
identifi
oligopeptid
also
map
templat
model
predict
access
antibodi
best
model
check
qualiti
qmean
server
model
except
qmean
score
around
indic
accept
model
accuraci
function
infer
psiblast
could
identifi
good
homologu
result
low
reliabl
itass
model
confirm
low
qmean
score
howev
due
lack
homolog
structur
protein
homolog
sequenc
henc
investig
could
provid
detail
inform
protein
potenti
function
local
structur
oligopeptid
identifi
phage
librari
screen
map
protein
model
gave
inform
local
immunogen
part
protein
sinc
region
elicit
antibodi
bind
investig
epitop
determin
like
linear
epitop
reveal
conform
epitop
might
form
within
oligopeptid
structur
present
phage
particl
furthermor
virulenceassoci
protein
identifi
increas
likelihood
discov
virulenceassoci
factor
among
identifi
protein
particularli
examin
addit
analys
characteris
immunogen
protein
conduct
care
attent
put
epitop
map
moreov
addit
studi
necessari
confirm
immunogen
charact
identifi
protein
also
invivo
furthermor
recombin
antibodi
select
protein
gener
assist
characteris
identifi
protein
final
identifi
protein
work
might
suitabl
target
develop
novel
therapeut
measur
n
gonorrrhoea
could
provid
crucial
inform
better
understand
gonococc
infect
isol
genom
dna
sequenc
strain
n
gonorrhoea
fa
grown
columbia
blood
agar
microaerophil
condit
h
ml
brainheartinfus
broth
bhi
supplement
fetal
calf
serum
fc
inocul
singl
coloni
grown
h
microaerophil
condit
rpm
polyclon
rabbit
antibodi
n
gonorrhoea
acri
lot
use
pan
round
initi
screen
goat
antirabbit
igg
fcspecif
biomol
lot
use
captur
antibodi
pan
procedur
three
differ
antibodi
n
gonorrhoea
separ
immunis
pool
individu
acri
lot
lot
abcam
lot
deploy
valid
fulllength
immunogen
protein
mous
antibodi
progen
lot
use
captur
oligopeptid
phage
particl
screen
elisa
colorimetr
readout
elisa
assay
achiev
polyclon
goat
secondari
antibodi
rabbit
igg
conjug
horseradish
peroxidas
abcam
lot
cell
harvest
centrifug
x
g
min
genom
dna
isol
phenol
chloroform
extract
genejet
genom
dna
purif
kit
thermo
scientif
dna
fragment
sonic
upon
extract
follow
protocol
repeat
six
time
ice
min
sonic
amplitud
cycl
set
follow
min
chill
ice
set
accord
bandelin
sonopul
sonotrod
subsequ
dna
concentr
use
amicon
ultra
ml
centrifug
filter
cutoff
kda
dna
fragment
size
bp
extract
agaros
gel
dna
end
repair
fast
dna
end
repair
kit
thermo
scientif
accord
manufactur
instruct
ng
fragment
dna
ligat
pmei
digest
vector
ng
follow
three
transform
per
ligat
e
coli
invitrogen
electropor
number
requir
clone
cover
genom
calcul
follow
equat
n
number
requir
clone
p
probabl
certain
fragment
present
set
averag
size
dna
insert
depend
librari
b
total
size
n
gonorrhoea
fa
genom
bp
librari
packag
use
hyperphag
describ
alter
packag
genom
dna
librari
hyperphag
orf
enrich
result
oligopeptid
present
phage
particl
pan
ml
ytga
yeasttrypton
broth
supplement
glucos
ampicillin
inocul
librari
stock
od
follow
infect
pellet
resuspend
ml
ytak
yt
contain
ampicillin
kanamycin
phage
particl
produc
rpm
overnight
cell
centrifug
min
x
g
phage
particl
supernat
precipit
volum
wv
polyethylen
glycol
nacl
solut
h
ice
gentl
shake
phage
particl
pellet
h
x
g
resuspend
ml
phage
dilut
buffer
mm
trishcl
ph
mm
nacl
mm
edta
remain
bacteria
pellet
addit
centrifug
step
min
x
g
subsequ
solut
filter
filter
filtrat
precipit
pegnacl
h
subsequ
centrifug
min
x
g
pellet
resuspend
ml
phage
dilut
buffer
residu
bacteri
cell
remov
centrifug
min
x
g
final
supernat
contain
oligopeptid
present
phage
store
phage
titr
determin
titrat
check
librari
qualiti
number
random
e
coli
coloni
analys
coloni
pcr
sequenc
packag
hyperphag
therefor
primer
mhlaczprof
mhgiiir
use
follow
pcr
protocol
cycl
final
extens
dna
separ
analys
capillari
electrophoresi
qiaxcel
advanc
addit
plasmid
dna
sequenc
primer
use
coloni
pcr
verifi
correct
insert
orf
enrich
packag
two
well
maxisorp
w
well
micropl
coat
goat
antirabbit
igg
fcspecif
antibodi
phosphat
buffer
salin
pb
overnight
subsequ
well
wash
thrice
pb
supplement
pbst
block
h
pbst
supplement
wv
milk
powder
mpbst
pan
well
two
well
maxisorp
w
well
plate
nunc
coat
x
cfu
hyperphag
pb
overnight
block
mpbst
h
polyclon
rabbit
antibodi
n
gonorrhoea
dilut
mpbst
preincub
twice
hyperphag
coat
well
h
elimin
igg
bind
helperphag
preincub
polyclon
antibodi
incub
h
well
coat
goat
antirabbit
igg
antibodi
n
gonorrhoea
phage
librari
correspond
x
cfu
oligopeptid
phage
particl
phage
librari
plu
mpbst
incub
well
captur
antin
gonorrhoea
antibodi
h
amplifi
phage
previou
pan
round
use
second
third
round
unbound
phage
low
affin
rins
ten
stringent
wash
step
pan
round
wash
step
increas
ten
total
number
three
pan
round
wash
bound
phage
particl
elut
trypsin
trypsin
pb
min
elut
phage
well
combin
use
titrat
remain
use
infect
ml
e
coli
cultur
grown
od
cell
incub
min
harvest
centrifug
min
x
g
pellet
resuspend
ytga
bacteri
suspens
plate
onto
cm
ytga
agar
plate
incub
overnight
coloni
swept
ml
ytga
medium
ml
ytga
medium
inocul
bacteri
suspens
od
grown
od
rpm
ml
bacteri
cultur
approx
x
cell
infect
ratio
result
x
cfu
hyperphag
suspens
incub
min
without
shake
anoth
min
rpm
dispos
glucos
inhibit
phage
express
infect
cell
harvest
centrifug
min
x
g
remain
pellet
resuspend
ml
ytak
incub
rpm
overnight
phage
product
bacteri
cell
pellet
centrifug
min
x
g
remain
supernat
use
phage
particl
precipit
pegnacl
wv
peg
nacl
ml
supernat
incub
h
ml
pegnacl
ice
slight
shake
rocker
follow
centrifug
x
g
h
phage
pellet
resuspend
phage
dilut
buffer
mm
trishcl
ph
mm
nacl
mm
edta
centrifug
microcentrifug
x
g
min
supernat
use
pan
round
elut
phage
particl
third
pan
round
amplifi
use
titrat
singl
coloni
use
singl
oligopeptid
phage
product
singl
oligopeptid
phage
clone
produc
inocul
ytga
medium
singl
coloni
titrat
plate
polypropylen
well
u
bottom
plate
greiner
bioon
cultur
incub
rpm
shake
overnight
ytga
medium
per
well
inocul
overnight
cultur
incub
rpm
h
subsequ
bacteria
infect
x
cfu
hyperphag
incub
min
without
shake
min
rpm
bacteria
pellet
centrifug
x
g
min
pellet
resuspend
ytak
incub
overnight
rpm
produc
phage
supernat
transfer
anoth
plate
precipit
volum
pegnacl
solut
h
next
precipit
phage
particl
pellet
centrifug
x
g
h
pellet
dissolv
pb
remain
bacteri
cell
separ
anoth
centrifug
step
phage
contain
supernat
store
new
plate
use
screen
elisa
oligopeptid
phage
particl
captur
monoclon
mous
progen
antibodi
screen
ngml
antibodi
pb
coat
overnight
subsequ
block
mpbst
well
wash
pbst
thrice
incub
step
monoclon
phage
clone
incub
h
polyclon
rabbit
antibodi
n
gonorrhoea
dilut
mpbst
supplement
e
coli
lysat
x
cfuml
hyperphag
per
ml
dilut
preincub
h
preincub
antibodi
incub
captur
phage
particl
h
detect
goat
antirabbit
igg
antibodi
conjug
horseradish
peroxidas
hrp
h
visualis
achiev
ad
tmb
solut
reaction
stop
n
sulphur
acid
absorb
yellow
colour
chang
measur
nm
use
fluostar
omega
micropl
reader
bmg
labtech
valid
immunogen
fulllength
protein
gene
amplifi
genom
dna
pcr
use
primer
list
tabl
gene
neg
control
amplifi
genom
dna
borrelia
burgdorferi
phusion
polymeras
thermo
scientif
use
amplif
fulllength
gene
accord
follow
protocol
anneal
temperatur
primer
depend
cycl
min
amplifi
gene
digest
two
restrict
enzym
case
ndei
noti
nhei
noti
gene
carri
signal
peptid
restrict
site
one
enzym
correspond
band
cut
agaros
gel
purifi
nucleospin
gel
pcr
cleanup
machereynagel
use
clone
appropri
digest
vector
ndeinoti
nheinoti
e
coli
cell
transform
ligat
plasmid
final
posit
clone
identifi
coloni
pcr
use
oligonucleotid
primer
sequenc
product
purif
fulllength
protein
ml
ytga
broth
inocul
ml
overnight
cultur
cultiv
baffl
flask
od
rpm
express
induc
final
concentr
mm
iptg
h
decreas
temperatur
follow
centrifug
x
g
min
cell
harvest
cell
lyse
protein
purifi
denatur
condit
resuspend
cell
pellet
histag
bind
buffer
ph
fulllength
protein
analys
sdspage
depend
expect
protein
size
gel
cast
accord
protocol
sambrook
russel
protein
sampl
mix
lane
marker
reduc
sampl
buffer
thermo
scientif
elisa
valid
immunogen
fulllength
protein
protein
coat
well
micropl
maxisorp
nunc
mm
nahco
ph
overnight
block
perform
mpbst
h
polyclon
rabbit
antibodi
n
gonorrhoea
dilut
mpbst
supplement
e
coli
lysat
incub
h
incub
step
well
wash
thrice
pbst
well
incub
rt
preincub
antibodi
h
bound
rabbit
igg
detect
goat
antirabbit
igg
antibodi
conjug
hrp
visualis
achiev
ad
tmb
solut
reaction
stop
ad
n
sulphur
acid
subsequ
absorb
measur
nm
use
fluostar
omega
micropl
reader
bmg
labtech
isol
total
rna
biolog
triplic
consist
ml
n
gonorrhoea
cultur
use
rna
isol
use
rnaprotect
bacteria
reagent
qiagen
rneasi
mini
kit
qiagen
follow
manufactur
instruct
addit
oncolumn
dna
digest
second
dna
digest
use
elimin
residu
dna
contamin
rna
integr
check
agil
bioanalyz
use
rna
pico
kit
agil
rna
integr
number
rin
lie
within
rang
higher
number
indic
intact
rna
low
number
refer
degrad
rna
first
strand
cdna
gener
revertaid
first
strand
cdna
synthesi
kit
thermo
scientif
accord
manufactur
instruct
use
random
hexam
primer
simultan
neg
control
revers
transcriptas
rt
templat
control
ntc
carri
express
annot
hypothet
protein
put
phage
associ
verifi
realtim
pcr
three
revers
transcrib
cdna
biolog
triplic
neg
control
templat
control
pcr
reaction
two
neg
control
revers
transcript
includ
part
gene
appli
posit
control
reaction
setup
maxima
sybr
green
qpcr
master
mix
thermo
scientif
follow
manufactur
instruct
first
strand
cdna
templat
realtim
pcr
run
roch
lightcycl
use
follow
program
min
cycl
singl
data
acquisit
elong
step
addit
melt
curv
record
start
slope
decreas
continu
fluoresc
acquisit
data
shown
primer
use
realtim
pcr
list
tabl
primer
manual
design
check
pcr
primer
stat
sequenc
manipul
suit
primer
qpcr
design
genescript
realtim
pcr
taqman
primer
design
sequenc
insert
identifi
blast
localis
predict
perform
psortb
signal
peptid
predict
use
signalp
structur
predict
use
itass
model
select
base
upon
cscore
confid
score
use
itass
estim
qualiti
predict
model
cscore
usual
rang
cscore
higher
valu
repres
model
high
confid
viceversa
model
visual
use
chimera
model
reliabl
addit
check
qmean
summari
avail
homologu
structur
obtain
run
psiblast
iter
pdb
databas
tabl
evalu
result
perform
microsoft
excel
originpro
g
originlab
support
inform
